+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Menopause Market by Treatment, Product Type, Indication, Distribution Challenge - Global Forecast 2025-2030- Product Image
Menopause Market by Treatment, Product Type, Indication, Distribution Challenge - Global Forecast 2025-2030- Product Image
Sale

Menopause Market by Treatment, Product Type, Indication, Distribution Challenge - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454968
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Menopause Market grew from USD 17.79 billion in 2023 to USD 18.99 billion in 2024. It is expected to continue growing at a CAGR of 6.85%, reaching USD 28.29 billion by 2030.

The scope of menopause-related market research encompasses various products and services catering to women undergoing menopause, with a focus on pharmaceuticals, supplements, lifestyle products, and healthcare services that address symptoms like hot flashes, osteoporosis, and hormonal imbalances. Necessity arises from widespread menopausal prevalence, estimated to affect millions of women globally each year, thereby presenting a lucrative opportunity for targeted innovation in health and wellness. Application and end-use scope extends across healthcare providers, pharmaceutical companies, lifestyle brands, and wellness centers, all striving to enhance quality of life during this transitional phase. Key growth drivers include increasing awareness about menopausal health issues, robust R&D in hormone replacement therapies, and a growing acceptance of holistic wellness approaches. Potential opportunities exist in the development of non-hormonal therapies, plant-based supplements, and digital health monitoring solutions tailored to menopausal needs. Firms that leverage data analytics to personalize treatment options stand to gain competitive advantage. Emerging markets in Asia-Pacific and Latin America present untapped potential owing to their large female populaces entering menopause, combined with increasing disposable incomes and healthcare spending. Nonetheless, challenges such as the societal stigma of menopause, high R&D costs, regulatory hurdles in drug approvals, and a fragmented market structure pose significant constraints. Addressing these involves enhancing consumer education to normalize menopause discussions, investing in cost-effective research, navigating complex regulatory landscapes, and pursuing cross-sector partnerships to streamline offerings. Innovation should focus on integrative health approaches, including AI-driven personalized medicine, wearable technology for symptom tracking, and eco-conscious product development. The market’s inherently dynamic nature necessitates continuous adaptation to emerging trends and technological advancements, emphasizing the importance of agility and foresightedness to capitalize on evolving consumer preferences and scientific breakthroughs.

Understanding Market Dynamics in the Menopause Market

The Menopause Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • High prevalence of vasomotor and other menopausal symptoms
    • Rising awareness regarding menopause health
    • Increasing number of new drug approvals for the treatment
  • Market Restraints
    • Side effects associated with hormonal products and the availability of generic medicines
  • Market Opportunities
    • Prevalence of herbal treatment for menopause
    • Increasing research supporting the advantages of dietary supplements
  • Market Challenges
    • Lack of advanced healthcare infrastructure in developing nations

Exploring Porter’s Five Forces for the Menopause Market

Porter’s Five Forces framework further strengthens the insights of the Menopause Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Menopause Market

External macro-environmental factors deeply influence the performance of the Menopause Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Menopause Market

The Menopause Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Menopause Market

The Menopause Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Menopause Market

The Menopause Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Menopause Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co.Inc., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc..

Market Segmentation & Coverage

This research report categorizes the Menopause Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment
    • Dietary Supplements
    • OTC Pharma Products
      • Hormonal products
        • Combination Estrogen and Other Medicines
        • Combination Estrogen and Progestin Medicines
        • Estrogen-Only Medicines
        • Progestin-Only Medicines
      • Non-hormonal products
  • Product Type
    • Gel
    • Injection
    • Oral Dosage
    • Patch
    • Pill
    • Powder
    • Skin Cream
    • Skin Spray (Transdermal)
    • Vaginal Cream
    • Vaginal Ring
  • Indication
    • Dry Eyes
    • Dry Skin
    • Hot Flashes
    • Mood Swings, Mild depression & Irritability
    • Night Sweats and Cold Flashes.
    • Osteoporosis
    • Trouble Sleeping
    • Urinary Urgency
    • Vaginal Dryness
  • Distribution Challenge
    • Hospital Pharmacies
    • Online Stores
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
5.1.1.2. Rising awareness regarding menopause health
5.1.1.3. Increasing number of new drug approvals for the treatment
5.1.2. Restraints
5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
5.1.3. Opportunities
5.1.3.1. Prevalence of herbal treatment for menopause
5.1.3.2. Increasing research supporting the advantages of dietary supplements
5.1.4. Challenges
5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Menopause Market, by Treatment
6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharma Products
6.3.1. Hormonal products
6.3.1.1. Combination Estrogen and Other Medicines
6.3.1.2. Combination Estrogen and Progestin Medicines
6.3.1.3. Estrogen-Only Medicines
6.3.1.4. Progestin-Only Medicines
6.3.2. Non-hormonal products
7. Menopause Market, by Product Type
7.1. Introduction
7.2. Gel
7.3. Injection
7.4. Oral Dosage
7.5. Patch
7.6. Pill
7.7. Powder
7.8. Skin Cream
7.9. Skin Spray (Transdermal)
7.10. Vaginal Cream
7.11. Vaginal Ring
8. Menopause Market, by Indication
8.1. Introduction
8.2. Dry Eyes
8.3. Dry Skin
8.4. Hot Flashes
8.5. Mood Swings, Mild depression & Irritability
8.6. Night Sweats and Cold Flashes.
8.7. Osteoporosis
8.8. Trouble Sleeping
8.9. Urinary Urgency
8.10. Vaginal Dryness
9. Menopause Market, by Distribution Challenge
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Stores
9.4. Retail Pharmacies
10. Americas Menopause Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Menopause Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Menopause Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
FIGURE 2. MENOPAUSE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MENOPAUSE MARKET DYNAMICS
TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND OTHER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND PROGESTIN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTIN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY ORAL DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY SKIN CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY SKIN SPRAY (TRANSDERMAL), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY DRY EYES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY DRY SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY MOOD SWINGS, MILD DEPRESSION & IRRITABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY NIGHT SWEATS AND COLD FLASHES., BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY TROUBLE SLEEPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MENOPAUSE MARKET SIZE, BY URINARY URGENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL DRYNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 62. CANADA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. CANADA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 64. CANADA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. MEXICO MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 94. CHINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. CHINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. CHINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. CHINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 100. INDIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. INDIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 102. INDIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 103. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 112. JAPAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. JAPAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 114. JAPAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 115. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. JAPAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. TAIWAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 148. THAILAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 149. THAILAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 150. THAILAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 151. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. THAILAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. VIETNAM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 156. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. VIETNAM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 167. DENMARK MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. DENMARK MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 169. DENMARK MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 170. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 173. EGYPT MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. EGYPT MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 175. EGYPT MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 176. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. EGYPT MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 179. FINLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. FINLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 181. FINLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. FINLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. FRANCE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 187. FRANCE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 188. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. FRANCE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 191. GERMANY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 192. GERMANY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. GERMANY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. ISRAEL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 199. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 200. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ISRAEL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 202. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 203. ITALY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 204. ITALY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 205. ITALY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 206. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ITALY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 208. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 221. NORWAY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 222. NORWAY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 223. NORWAY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 224. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. NORWAY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 227. POLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. POLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 229. POLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 230. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. POLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 232. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 233. QATAR MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 234. QATAR MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 235. QATAR MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 236. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. QATAR MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 257. SPAIN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 258. SPAIN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 259. SPAIN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 260. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SPAIN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 275. TURKEY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 276. TURKEY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 278. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. TURKEY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 280. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 292. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 293. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 294. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Menopause Market, which are profiled in this report, include:
  • Abbvie Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Cipla Inc.
  • Eli Lilly and Company
  • Fervent Pharmaceuticals, LLC
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Merck & Co.Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 18.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 28.29 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Menopause Global Market Report 2024 - Product Image

Menopause Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Vasomotor Symptoms of Menopause - Pipeline Insight, 2024 - Product Image

Vasomotor Symptoms of Menopause - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Menopause Associated Vasomotor Symptoms - Pipeline Insight, 2024 - Product Image

Menopause Associated Vasomotor Symptoms - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Women's Health App Market Size, Share & Trends Analysis Report By Type (Fitness & Nutrition, Pregnancy Tracking & Postpartum Care, Menopause), By Modality, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Women's Health App Market Size, Share & Trends Analysis Report By Type (Fitness & Nutrition, Pregnancy Tracking & Postpartum Care, Menopause), By Modality, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 83 Pages
  • Global
From
Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From

About the Market

The Menopause market is a subset of the Women's Health industry, focusing on the physical and emotional changes experienced by women during the transition from reproductive to non-reproductive years. It includes products and services that help women manage the symptoms of menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness. It also includes treatments for conditions associated with menopause, such as osteoporosis, heart disease, and urinary incontinence. The Menopause market is a growing industry, with an increasing number of products and services available to women. Companies in the market include pharmaceutical companies, health care providers, and wellness companies. Examples include Hormone Health Network, Menopause Solutions, and Menopause Support. Additionally, there are a number of online resources and support groups available to women going through menopause. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.